The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/Lipocalin-2 as a biomarker for lupus nephritis

Autoimmunity Reviews

Volumn 7, Issue 3, 2008, Pages 229-234

  Rubinstein, Tamar ^a   Pitashny, Milena ^a,b   Putterman, Chaim ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Biomarkers; Lipocalin 2; Lupus nephritis; Neutrophil gelatinase B associated lipocalin; NGAL; Systemic lupus erythematosus

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; IRON; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TOLL LIKE RECEPTOR;

APOPTOSIS; DISEASE ACTIVITY; DNA SCREENING; HUMAN; IN VITRO STUDY; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RENAL PROTECTION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; HUMANS; LIPOCALINS; LUPUS NEPHRITIS; PROTO-ONCOGENE PROTEINS;

EID: 37649022459     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.11.013     Document Type: Review

References (30)

1. Fiehn C. Early diagnosis and treatment in lupus nephritis: how we can influence the risk for terminal renal failure. J Rheumatol 33 (2006) 1464-1466
2. Brunner H.I., Mueller M., Rutherford C., Passo M.H., Witte D., Grom A., et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum 54 (2006) 2577-2584
3. Liu C.C., Manzi S., and Ahearn J.M. Biomarkers for systemic lupus erythematosus: a review and perspective. Curr Opin Rheumatol 17 (2005) 543-549
4. Tong Z., Wu X., Ovcharenko D., Zhu J., Chen C.S., and Kehrer J.P. Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem J 391 (2005) 441-448
5. Pawluczyk I.Z., Furness P.N., and Harris K.P. Macrophage-induced rat mesangial cell expression of the 24p3-like protein alpha-2-microglobulin-related protein. Biochim Biophys Acta 1645 (2003) 218-227
6. Rudd P.M., Mattu T.S., Masure S., Bratt T., Van den Steen P.E., Wormald M.R., et al. Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin. Biochemistry 38 (1999) 13937-13950
7. Cowland J.B., and Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45 (1997) 17-23
8. Fernandez C.A., Yan L., Louis G., Yang J., Kutok J.L., and Moses M.A. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11 (2005) 5390-5395
9. Schmidt-Ott K.M., Mori K., Li J.Y., Kalandadze A., Cohen D.J., Devarajan P., et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 18 (2007) 407-413
10. Devireddy L.R., Gazin C., Zhu X., and Green M.R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123 (2005) 1293-1305
11. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432 (2004) 917-921
12. Yang J., Goetz D., Li J.Y., Wang W., Mori K., Setlik D., et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 10 (2002) 1045-1056
13. Yang J., Mori K., Li J.Y., and Barasch J. Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol 285 (2003) F9-F18
14. Devireddy L.R., Teodoro J.G., Richard F.A., and Green M.R. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293 (2001) 829-834
15. Berger T., Togawa A., Duncan G.S., Elia A.J., You-Ten A., Wakeham A., et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA 103 (2006) 1834-1839
16. Ryon J., Bendickson L., and Nilsen-Hamilton M. High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J 367 (2002) 271-277
17. Nielsen B.S., Borregaard N., Bundgaard J.R., Timshel S., Sehested M., and Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38 (1996) 414-420
18. Liu Q., and Nilsen-Hamilton M. Identification of a new acute phase protein. J Biol Chem. 270 (1995) 22565-22570
19. Mori K., Lee H.T., Rapoport D., Drexler I.R., Foster K., Yang J., et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115 (2005) 610-621
20. Hemdahl A.L., Gabrielsen A., Zhu C., Eriksson P., Hedin U., Kastrup J., et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 26 (2006) 136-142
21. Biezeveld M.H., van Mierlo G., Lutter R., Kuipers I.M., Dekker T., Hack C.E., et al. Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin Exp Immunol 141 (2005) 183-188
22. Xu S., and Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta 1482 (2000) 298-307
23. Mishra J., Ma Q., Prada A., Mitsnefes M., Zahedi K., Yang J., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14 (2003) 2534-2543
24. Ka S.M., Rifai A., Chen J.H., Cheng C.W., Shui H.A., Lee H.S., et al. Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease. Nephrol Dial Transplant 21 (2006) 288-298
25. Mishra J., Dent C., Tarabishi R., Mitsnefes M.M., Ma Q., Kelly C., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365 (2005) 1231-1238
26. Trachtman H., Christen E., Cnaan A., Patrick J., Mai V., Mishra J., et al. Urinary neutrophil gelatinase-associated lipocalcin in D + HUS: a novel marker of renal injury. Pediatr Nephrol 21 (2006) 989-994
27. Mishra J., Mori K., Ma Q., Kelly C., Barasch J., and Devarajan P. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 24 (2004) 307-315
28. Mitsnefes M.M., Kathman T.S., Mishra J., Kartal J., Khoury P.R., Nickolas T.L., et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 22 (2007) 101-108
29. Qing X., Zavadil J., Crosby M.B., Hogarth M.P., Hahn B.H., Mohan C., et al. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum 54 (2006) 2198-2210
30. Pitashny M., Schwartz N., Qing X., Hojaili B., Aranow C., Mackay M., et al. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum 56 (2007) 1894-1903